KURNKuros Biosciences AG
21.52CHF-4.19%Mkt Cap: 974.37M $P/E: 113.26

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two se…

Key Statistics

Company
Market Cap974.37M $
Enterprise Value
Revenue (TTM)199.65M $
Gross Profit186.49M $
Net Income (TTM)3.68M $
Revenue/Share5.209 USD
Last Price21.52 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees178
CountryCH
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)113.26
P/E (Forward)42.02
PEG
EV/EBITDA
EV/Revenue
P/S4.91
P/B12.38
EPS (TTM)0.19
EPS (Forward)0.52
52W Range
17.6923% of range34.20
52W High34.20 CHF
52W Low17.69 CHF
Profitability
Gross Margin88.60%
Oper. Margin5.61%
EBITDA Margin7.65%
Profit Margin1.75%
ROE3.02%
ROA1.91%
Growth
Revenue Growth45.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-655.74K $
CapEx (TTM)3.52M $
FCF Margin
FCF Yield
Net Debt
Net Debt/EBITDA
Balance Sheet
Debt/Equity0.02
Current Ratio
Quick Ratio
Book Value/Sh1.750 CHF
Cash/Share
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CHF
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateOct 8, 2020
Splits
Last Split1:100
Split DateJun 23, 2016
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.92 CHF
Upside (mean)+57.6%
Target Range32.00 CHF38.00 CHF
CHF32.00+57.6% to meanCHF38.00
# Analysts4
Ownership
Shares Out.39.67M
Float29.66M
Insiders28.74%
Institutions22.00%
Technical
SMA 5020.75 (+3.7%)
SMA 20024.09 (-10.7%)
Beta0.76
S&P 52W Chg18.16%
Avg Vol (30d)176.99K
Avg Vol (10d)208.57K
Technical Indicators
RSI (14)54.5
MACD0.4913
MACD Signal0.6021
MACD Hist.-0.1107
BB Upper24.59 CHF
BB Middle22.17 CHF
BB Lower19.75 CHF
BB Width21.82%
ATR (14)1.160 CHF
Vol Ratio (20d)1.20x